ClinConnect ClinConnect Logo
Search / Trial NCT04096430

Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)

Launched by UNIVERSITY OF ALBERTA · Sep 17, 2019

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way of setting goals for children with disabilities who are receiving rehabilitation therapy. The focus is on a child-friendly approach called the ENGAGE method, which encourages children aged 5 to 12 years with conditions like Autism Spectrum Disorder, Cerebral Palsy, and other neurodevelopmental disorders to be active participants in deciding their therapy goals. By comparing this new method to the usual therapy practices, researchers hope to find out if ENGAGE helps children perform better, feel more satisfied with their progress, and improve their overall quality of life.

To participate, children need to be between 5 and 12 years old, have a diagnosed disability, and be able to engage in the goal-setting process. They should also be receiving physical or occupational therapy and speak English. During the trial, children will either follow the ENGAGE approach or the standard therapy approach, depending on which group their therapist is assigned to. Parents and children will also share their experiences and thoughts on how well the ENGAGE method worked. This study aims to find better ways to help children and their families succeed in rehabilitation and to see which method is more cost-effective for therapy services.

Gender

ALL

Eligibility criteria

  • Inclusion criteria are children with a diagnosed disability who:
  • 1. are between the ages of 5-12 years
  • 2. are able to engage in the goal-setting process (determined by therapists)
  • 3. are referred to PT and/or OT for a period of direct treatment
  • 4. speak English.
  • Children will be excluded from the trial if:
  • 1. the parent or guardian who attends therapy does not speak English
  • 2. the child has a diagnosis that suggests developmental regression
  • 3. the child has uncontrolled seizures (i.e., seizure within the past 2 months).

About University Of Alberta

The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.

Locations

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Camrose, Alberta, Canada

Edmonton, Alberta, Canada

Grande Prairie, Alberta, Canada

Red Deer, Alberta, Canada

Patients applied

0 patients applied

Trial Officials

Lesley Pritchard-Wiart, PhD

Principal Investigator

University of Alberta, Faculty of Rehabilitation Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials